Proteins as biomarkers of oxidattiv/e/nitrosative stress in diseases: The contribution of redox proteomics

Mass Spectrometry Reviews

Volumn 24, Issue 1, 2005, Pages 55-99

  Dalle Donne, Isabella ^a   Scaloni, Andrea ^b   Giustarini, Daniela ^c   Cavarra, Eleonora ^c   Tell, Gianluca ^d   Lungarella, Giuseppe ^c   Colombo, Roberte ^a   Rossi, Ranieri ^c   Milzani, Aldo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d UNIVERSITY OF UDINE   (Italy)

Author keywords

Biological markers; Mass spectrometry; Methionine sulfoxide; Nitrosothiols; Nitrotyrosine; Protein carbonylation; Protein oxidation; Proteomics; Reactive nitrogen species; Reactive oxygen species; S glutathionylation; S nitrosation

Indexed keywords

BIOMARKERS; DISEASE CONTROL; DISEASES; MASS SPECTROMETERS; MASS SPECTROMETRY; MEDICINE; MOLECULAR BIOLOGY; OXIDATION; OXYGEN; REDOX REACTIONS;

BIOLOGICAL MARKERS; METHIONINE SULFOXIDE; NITROSOTHIOLS; NITROTYROSINE; PROTEIN CARBONYLATION; PROTEIN OXIDATION; PROTEOMICS; REACTIVE NITROGEN SPECIES (RNS); REACTIVE OXYGEN SPECIES (ROS); S-NITROSATION;

PROTEINS;

PROTEIN;

GENERAL ASPECTS OF DISEASE; HUMAN; NITROSATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PROTEOMICS; REVIEW;

DISEASE; HUMANS; NITROSATION; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEINS; PROTEOMICS;

EID: 12444296480     PISSN: 02777037     EISSN: None     Source Type: Journal    
DOI: 10.1002/mas.20006     Document Type: Article

References (357)

1. Abu-Zidan FM, Plank LD, Windsor J.A. 2002. Proteolysis in severe sepsis is related to oxidation of plasma protein. Eur J Surg 168:119-123.
2. Ahn B, Rhee SG, Stadtman ER. 1987. Use of fluorescein hydrazide and fluorescein thiosemicarbazide reagents for the fluorometric determination of protein carbonyl groups and for the detection of oxidized protein on polyacrylamide gels. Anal Biochem 161:245-257.
3. Aksenov MY, Aksenova MV, Butterfield DA, Geddes JW, Markesbery WR. 2001. Protein oxidation in the brain in Alzheimer's disease. Neuroscience 103:373-383.
4. Al-Abed Y, VanPatten S, Li H, Lawson JA, Fitzgerald GA, Manogue KR, Bucala R. 2001. Characterization of a novel hemoglobin-glutathione adduct that is elevated in diabetic patients. Mol Med 7:619-623.
5. Alderton AL, Faustman C, Liebler DC, Hill DW. 2003. Induction of redox instability of bovine myoglobin by adduction with 4-hydroxy-2-nonenal. Biochemistry 42:4398-4405.
6. Aldridge RE, Chan T, Van Dalen CJ, Senthilmohan R, Winn M, Venge P, Town GI, Kettle AJ. 2002. Eosinophil peroxidase produces hypobromous acid in the airways of stable asthmatics. Free Radic Biol Med 33:847-856.
7. Alexander MD, Traynor BJ, Miller N, Corr B, Frost E, McQuaid S, Brett FM, Green A, Hardiman O. 2002. "True" sporadic ALS associated with a novel SOD-1 mutation. Ann Neurol 52:680-683.
8. Almer G, Guegan C, Teismann P, Naini A, Rosoklija G, Hays AP, Chen C, Przedborski S. 2001. Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis. Ann Neurol 49:176-185.
9. Altomare E, Grattagliano I, Vendemaile G, Micelli-Ferrari T, Signorile A, Cardia L. 1997. Oxidative protein damage in human diabetic eye: Evidence of a retinal participation. Eur J Clin Invest 27:141-147.
10. Anderson LB, Maderia M, Ouellette AJ, Putnam-Evans C, Higgins L, Krick T, MacCoss MJ, Lim H, Yates JR III, Barry BA. 2002. Posttranslational modifications in the CP43 subunit of photosystem II. Proc Natl Acad Sci USA 99:14676-14681.
11. Andreadis AA, Hazen SL, Comhair SAA, Erzurum SC. 2003. Oxidative and nitrosative events in asthma. Free Radic Biol Med 35:213-225.
12. Aoyama K, Matsubara K, Fujikawa Y, Nagahiro Y, Shimizu K, Umegae N, Hayase N, Shiono H, Kobayashi S. 2000. Nitration of manganese Superoxide dismutase in cerebrospinal fluids is a marker for peroxynitrite-mediated oxidative stress in neurodegenerative diseases. Ann Neurol 47:524-527.
13. Arner ES, Holmgren A. 2000. Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem 267:6102-6109.
14. Aslan M, Ryan TM, Townes TM, Coward L, Kirk MC, Barnes S, Alexander CB, Rosenfeld SS, Freeman BA. 2003. Nitric oxide-dependent generation of reactive species in sickle cell disease. Actin tyrosine nitration induces defective cytoskeletal polymerization. J Biol Chem 278:4194-4204.
15. ATS Committee. 1995. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 152:S77-S120.
16. Aulak KS, Miyagi M, Yan L, West KA, Massillon D, Crabb JW, Stuehr DJ. 2001. Proteomic method identifies proteins nitrated in vivo during inflammatory challenge. Proc Natl Acad Sci USA 98:12056-12061.
17. Bagasra O, Michaels FH, Zheng YM, Bobroski LE, Spitsin SV, Fu ZF, Tawadros R, Koprowski H. 1995. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc Natl Acad Sci USA 92:12041-12045.
18. Balabanli B, Kamisaki Y, Martin E, Murad F. 1999. Requirements for heme and thiols for the nonenzymatic modification of nitrotyrosine. Proc Natl Acad Sci USA 96:13136-13141.
19. Baldus S, Eiserich JP, Brennan M-L, Jackson RM, Alexander CB, Freeman BA. 2002. Spatial mapping of pulmonary and vascular nitrotyrosine reveals the pivotal role of myeloperoxidase as a catalyst for tyrosine nitration in inflammatory diseases. Free Radic Biol Med 33:1010-1019.
20. Bandeira-Melo C, Bozza PT, Weller PF. 2002. The cellular biology of eosinophil eicosanoid formation and function. J Allergy Clin Immunol 109:393-400.
21. Barden A, Ritchie J, Walters B, Michael C, Rivera J, Mori T, Croft K, Beilin L. 2001. Study of plasma factors associated with neutrophil activation and lipid peroxidation in pre-eclampsia. Hypertension 38:803-808.
22. Baynes JW. 1991. Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-412.
23. Baynes JW, Thorpe SR. 1999. Role of oxidative stress in diabetic complications: A new perspective on an old paradigm. Diabetes 48:1-9.
24. Baynes JW, Thorpe SR. 2000. Glycoxidation and lipoxidation in atherogenesis. Free Radic Biol Med 28:1708-1716.
25. Beal MF. 2002. Oxidatively modified proteins in aging and disease. Free Radic Biol Med 32:797-803.
26. Beal MF, Ferrante RJ, Browne SE, Matthews RT, Kowall NW, Brown RH, Jr. 1997. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann Neurol 42:646-654.
27. Behr J, Maier K, Braun B, Schwaiblmair M, Vogelmeier C. 2000. Evidence for oxidative stress in bronchiolitis obliterans syndrome after lung and heart-lung transplantation. The Munich Lung Transplant Group. Transplantation 69:1856-1860.
28. Bennaars-Eiden A, Higgins L, Hertzel AV, Kapphahn RJ, Ferrington DA, Bernlohr DA. 2002. Covalent modification of epithelial fatty acid-binding protein by 4-hydroxynonenal in vitro and in vivo. Evidence for a role in antioxidant biology. J Biol Chem 277:50693-50702.
29. Berlett BS, Levine RL, Stadtman ER. 1998. Carbon dioxide stimulates peroxynitrite-mediated nitration of tyrosine residues and inhibits oxidation of methionine residues of glutamine synthetase: Both modifications mimic effects of adenylylation. Proc Natl Acad Sci USA 95:2784-2789.
30. Berlett BS, Stadtman ER. 1997. Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 272:20313-20316.
31. Bhattacharjee S, Pennathur S, Byun J, Crowley J, Mueller D, Gischler J, Hotchkiss RS, Heinecke JW. 2001. NADPH oxidase of neutrophils elevates o,o′-dityrosine cross-links in proteins and urine during inflammation. Arch Biochem Biophys 395:69-77.
32. Biemel KM, Friedl DA, Lederer MO. 2002. Identification and quantification of major maillard cross-links in human serum albumin and lens protein. Evidence for glucosepane as the dominant compound. J Biol Chem 277:24907-24915.
33. Biemel KM, Reihl O, Conrad J, Lederer MO. 2001. Formation pathways for lysine-arginine cross-links derived from hexoses and pentoses by Maillard processes: Unraveling the structure of a pentosidine precursor. J Biol Chem 276:23405-23412.
34. Bowler RP, Crapo JD. 2002. Oxidative stress in airways: Is there a role for extracellular Superoxide dismutase? Am J Respir Crit Care Med 166:538-43.
35. Brown DR, Nicholas RS, Canevari L. 2002. Lack of prion protein expression results in a neuronal phenotype sensitive to stress. J Neurosci Res 67:211-224.
36. Buss H, Darlow BA, Winterbourn CC. 2000. Elevated protein carbonyls and lipid peroxidation products correlating with myeloperoxidase in tracheal aspirates from premature infants. Pediatr Res 47:640-645.
37. Buss IH, Senthilmohan R, Darlow BA, Mogridge N, Kettle AJ, Winterbourn CC. 2003. 3-Chlorotyrosine as a marker of protein damage by myeloperoxidase in tracheal aspirates from preterm infants: Association with adverse respiratory outcome. Pediatr Res 53:455-462.
38. Butterfield DA, Kanski J. 2001. Brain protein oxidation in age related neurodegenerative disorders that are associated with aggregated proteins. Mech Ageing Devel 122:945-962.
39. Butterfield DA, Lauderback CM. 2002. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: Potential causes and consequences involving amyloid beta-peptide associated free radical oxidative stress. Free Radic Biol Med 32:1050-1060.
40. Butterfield DA, Drake J, Pocernich C, Castegna A. 2001. Evidence of oxidative damage in Alzheimer's disease brain: Central role for amyloid beta-peptide. Trends Mol Med 7:548-554.
41. Butterfield DA, Castegna A, Lauderback CM, Drake J. 2002. Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol Aging 23:655-664.
42. Buttery LD, Springall DR, Chester AH, Evans TJ, Standfield EN, Parums DV, Yacoub MH, Polak JM. 1996. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Investig 75:77-85.
43. Cai H, Harrison DG. 2000. Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress. Circ Res 87:840-844.
44. Cakatay U, Telci A, Salman S, Satman L, Sivas A. 2000. Oxidative protein damage in type I diabetic patients with and without complications. Endocr Res 26:365-379.
45. Calabrese V, Scapagnini G, Ravagna A, Bella R, Foresti R, Bates TE, Giuffrida Stella AM, Pennisi G. 2002. Nitric oxide synthase is present in the cerebrospinal fluid of patients with active multiple sclerosis and is associated with increases in cerebrospinal fluid protein nitrotyrosine and S-nitrosothiols and with changes in glutathione levels. J Neurosci Res 70:580-587.
46. Calabrese V, Scapagnini G, Ravagna A, Bella R, Butterfield DA, Calvani M, Pennisi G, Giuffrida Stella AM. 2003. Disruption of thiol homeostasis and nitrosative stress in the cerebrospinal fluid of patients with active multiple sclerosis: Evidence for a protective role of acetyIcarnitine. Neurochem Res 28:1321-1328.
47. 2. J Biol Chem 273:32554-32560.
48. Castegna A, Aksenov M, Aksenova M, Thongboonkerd V, Klein J, Pierce W, Booze R, Markesbery W, Butterfield D. 2002a. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: Creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radic Biol Med 33:562-571.
49. Castegna A, Aksenov M, Thongboonkerd V, Klein JB, Pierce WM, Booze R, Markesbery WR, Butterfield DA. 2002b. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: Dihydropyrimidinase related protein 2, α-enolase and heat shock cognate 71. J Neurochem 82:1524-1532.
50. Castegna A, Thongboonkerd V, Klein JB, Lynn B, Markesbery WR, Butterfield DA. 2003. Proteomic identification of nitrated proteins in Alzheimer's disease brain. J Neurochem 85:1394-1401.
51. 1-proteinase inhibitor and sensitivity to oxidants. Am J Respir Crit Care Med 164:886-890.
52. Cecconi I, Scaloni A, Rastelli G, Moroni M, Vilardo PG, Costantino L, Cappiello M, Garland D, Carper D, Petrash JM, Del Corso A, Mura U. 2002. Oxidative modification of aldose reductase induced by copper ion. Definition of the metal-protein interaction mechanism. J Biol Chem 277: 42017-42027.
53. Ceriello A, Mercuri F, Quagliaro L, Assaloni R, Motz E, Tonutti L, Taboga C. 2001. Detection of nitrotyrosine in the diabetic plasma: Evidence of oxidative stress. Diabetologia 44:834-838.
54. Ceriello A, Quagliaro L, Catone B, Pascon R, Piazzola M, Bais B, Marra G, Tonutti L, Taboga C, Motz E. 2002. Role of hyperglycemia in nitrotyrosine postprandial generation. Diabetes Care 25:1439-1443.
55. Chen K, Thomas SR, Keaney JF, Jr. 2003. Beyond LDL oxidation: ROS in vascular signal transduction. Free Radic Biol Med 35:117-132.
56. Choi J, Malakowsky CA, Talent JM, Conrad CC, Gracy RW. 2002. Identification of oxidized plasma proteins in Alzheimer's disease. Biochem Biophys Res Commun 293:1566-1570.
57. 25-35 in Alzheimer's fibroblasts. Biochim Biophys Acta 1637:135-141.
58. Ciriolo MR, Paci M, Sette M, De Martino A, Bozzi A, Rotilio G. 1993. Transduction of reducing power across the plasma membrane by reduced glutathione. A 1H-NMR spin-echo study of intact human erythrocytes. Eur J Biochem 215:711-718.
59. Collinge J. 2001. Prion diseases of humans and animals: Their causes and molecular basis. Annu Rev Neurosci 24:519-550.
60. Comhair SA, Erzurum SC. 2002. Antioxidant responses to oxidant-mediated lung diseases. Am J Physiol Lung Cell Mol Physiol 283:L246-L255.
61. Conrad CC, Marshall PL, Talent JM, Malakowsky CA, Choi J, Gracy RW. 2000. Oxidized proteins in Alzheimer's plasma. Biochem Biophys Res Commun 275:678-681.
62. Cotgreave IA, Gerdes RG. 1998. Recent trends in glutathione biochemistry-glutathione-protein interactions: A molecular link between oxidative stress and cell proliferation? Biochem Biophys Res Commun 242:1-9.
63. Crabb JW, O'Neil J, Miyagi M, West K, Hoff HF. 2002. Hydroxynonenal inactivates cathepsin B by forming Michael adducts with active site residues. Protein Sci 11:831-840.
64. Dalle-Donne I, Milzani A, Giustarini D, Di Simplicio P, Colombo R, Rossi R. 2000. S-NO-actin: 5-nitrosylation kinetics and the effect on isolated vascular smooth muscle. J Muscle Res Cell Motil 21:171-181.
65. Dalle-Donne I, Rossi R, Giustarini D, Gagliano N, Lusini L, Milzani A, Di Simplicio P, Colombo R. 2001. Actin carbonylation: From a simple marker of protein oxidation to relevant signs of severe functional impairment. Free Radic Biol Med 31:1075-1083.
66. Dalle-Donne I, Rossi R, Giustarini D, Gagliano N, Di Simplicio P, Colombo R, Milzani A. 2002. Methionine oxidation as a major cause of the functional impairment of oxidized actin. Free Radic Biol Med 32:927-937.
67. Dalle-Donne I, Giustarini D, Rossi R, Colombo R, Milzani A. 2003a. Reversible 5-glutathionylation of Cys(374) regulates actin filament formation by inducing structural changes in the actin molecule. Free Radic Biol Med 34:23-32.
68. Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R. 2003b. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 329:23-38.
69. Dalle-Donne I, Giustarini D, Colombo R, Rossi R, Milzani A. 2003c. Protein carbonylation in human diseases. Trends Mol Med 9:169-176.
70. Dalle-Donne I, Rossi R, Giustarini D, Colombo R, Milzani A. 2003d. Actin S-glutathionylation: Evidence against a role for glutathione disulfide. Free Radic Biol Med 35:1185-1193.
71. Davies C, Blake D, Winyard P. 2001. Radicals in inflammation: Mediators and modulators. In: Fuchs J, Packer L, editors. Environmental Stressors: Effects on lung, skin, eye, and immune system function. New York: Marcel Dekker. pp 17-52.
72. Davies MJ, Dean RT. 1997. Radical-mediated protein oxidation. From chemistry to medicine. The pathology of protein oxidation. New York: Oxford University Press, Inc.
73. Davies MJ, Fu S, Wang H, Dean RT. 1999. Stable markers of oxidant damage to proteins and their application in study of human disease. Free Radic Biol Med 27:1151-1161.
74. Davis DA, Newcomb FM, Moskovitz J, Wingfield PT, Stahl SJ, Kaufman J, Fales HM, Levine RL, Yarchoan R. 2000. HIV-2 protease is inactivated after oxidation at the dimer interface and activity can be partly restored with methionine solfoxide reductase. Biochem J 346:305-311.
75. Davis KL, Martin E, Turko IV, Murad F. 2001. Novel effects of nitric oxide. Annu Rev Pharmacol Toxicol 41:203-236.
76. De Andrade JA, Crow JP, Viera L, Bruce Alexander C, Randall Young K, McGiffin DC, Zorn GL, Zhu S, Matalon S, Jackson RM. 2000. Protein nitration, metabolites of reactive nitrogen species, and inflammation in lung allografts. Am J Respir Crit Care Med 161:2035-2042.
77. Dean RT, Fu S, Stocker R, Davies MJ. 1997. Biochemistry and pathology of radical-mediated protein oxidation. Biochem J 324:1-18.
78. Dekhuijzen PN, Aben KK, Dekker I, Aarts LP, Wielders PL, van Herwaarden CL, Bast A. 1996. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 154:813-816.
79. Depre C, Havaux X, Renkin J, Vanoverschelde JL, Wijns W. 1999. Expression of inducible nitric oxide synthase in human coronary atherosclerotic plague. Cardiovasc Res 41:465-472.
80. Domigan NM, Charlton TS, Duncan MW, Winterbourn CC, Kettle AJ. 1995. Chlorination of tyrosyl residues in peptides by myeloperoxidase and human neutrophils. J Biol Chem 270:16542-16548.
81. Dominguez C, Ruiz E, Gussinye M, Carrascosa A. 1998. Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents. Diabetes Care 21:1736-1742.
82. Dong J, Atwood CS, Anderson VE, Siedlak SL, Smith MA, Perry G, Carey PR. 2003. Metal binding and oxidation of amyloid- ß, within isolated senile plaque cores: Raman microscopic evidence. Biochemistry 42:2768-2773.
83. Duda JE, Giasson BI, Chen Q, Gur TL, Hurtig HI, Stern MB, Gollomp SM, Ischiropoulos H, Lee VMY, Trojanowski JQ. 2000. Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies. Am J Pathol 157: 1439-1445.
84. Dweik RA, Comhair SA, Gaston B, Thunnissen FB, Farver C, Thomassen MJ, Kavuru M, Hammel J, Abu-Soud HM, Erzurum SC. 2001. NO chemical events in the human airway during the immediate and late antigen-induced asthmatic response. Proc Natl Acad Sci USA 98:2622-2627.
85. Dworski R. 2000. Oxidant stress in asthma. Thorax 55:S51-S53.
86. Eaton P, Fuller W, Shattock MJ. 2002a. S-Thiolation of HSP27 regulates its multimeric aggregate size independently of phosphorylation. J Biol Chem 277:21189-21196.
87. Eaton P, Wright N, Hearse DJ, Shattock MJ. 2002b. Glyceraldehyde phosphate dehydrogenase oxidation during cardiac ischemia and reperfusion. J Mol Cell Cardiol 34:1549-1560.
88. Eaton P, Byers HL, Leeds N, Ward MA, Shattock MJ. 2002c. Detection, quantitation, purification, and identification of cardiac proteins S-thiolated during ischemia and reperfusion. J Biol Chem 277:9806-9811.
89. Eaton P, Jones ME, McGregor E, Dunn MJ, Leeds N, Byers HL, Leung K-I, Ward MA, Pratt JR, Shattock MJ. 2003. Reversible cysteine-targeted oxidation of proteins during renal oxidative stress. J Am Soc Nephrol 14:S290-S296.
90. Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B, van der Vliet A. 1998. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 391:393-397.
91. Eiserich JP, Estevez AG, Bamberg TV, Ye YZ, Chumley PH, Beckman JS, Freeman BA. 1999. Microtubule dysfunction by posttranslational nitrotyrosination of alpha-tubulin: A nitric oxide-dependent mechanism of cellular injury. Proc Natl Acad Sci USA 96:6365-6370.
92. Elbim C, Fillet S, Prevost MH, Preira A, Girard PM, Rogine N, Hakim J, Israel N, Gougerot-Pocidalo MA. 2001. The role of phagocytes in HIV-related oxidative stress. J Clin Virol 20:99-109.
93. Esposito E, Rotilio D, Di Matteo V, Di Giulio C, Cacchio M, Algeri S. 2002. A review of specific dietary antioxidants and the effects on biochemical mechanisms related to neurodegenerative processes. Neurobiol Aging 23:719-735.
94. Ferranti P, Malorni A, Mamone G, Sannolo N, Marino G. 1997. Characterisation of S-nitrosohaemoglobin by mass spectrometry. FEES Lett 400:19-24.
95. Finley EL, Dillon J, Crouch RK, Schey KL. 1998. Identification of tryptophan oxidation products in bovine alpha-crystallin. Protein Sci 7:2391-2397.
96. Frand AR, Cuozzo JW, Kaiser CA. 2000. Pathways for protein disulphide bond formation. Trends Cell Biol 10:203-210.
97. Fratelli M, Demol H, Puype M, Casagrande S, Eberini I, Salmona M, Bonetto V, Mengozzi M, Duffieux F, Miclet E, Bachi A, Vandekerckhove J, Gianazza E, Ghezzi P. 2002. Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human T lymphocytes. Proc Natl Acad Sci USA 99:3505-3510.
98. Frost MT, Halliwell B, Moore KP. 2000. Analysis of free and protein-bound nitrotyrosine in human plasma by a gas chromatography/ mass spectrometry method that avoids nitration artifacts. Biochem J 345:453-458.
99. Frustaci A, Kajstura J, Chimenti C, Jakoniuk I, Leri A, Maseri A, Nadal-Ginard B, Anversa P. 2000. Myocardial cell death in human diabetes. Circ Res 87:1123-1132.
100. Fu S, Davies MJ, Stocker R, Dean RT. 1998. Evidence for roles of radicals in protein oxidation in advanced human atherosclerotic plaque. Biochem J 333:519-525.
101. Fu S, Wang H, Davies M, Dean R. 2000. Reactions of hypochlorous acid with tyrosine and peptidyl-tyrosyl residues give dichlorinated and aldehydic products in addition to 3-chlorotyrosine. J Biol Chem 275:10851-10858.
102. Fukuyama N, Takebayashi Y, Hida M, Ishida H, Ichimori K, Nakazawa H. 1997. Clinical evidence of peroxynitrite formation in chronic renal failure patients with septic shock. Free Radic Biol Med 22:771-774.
103. Gabbita SP, Askenov MY, Lovell MA, Markesbery WR. 1999. Decrease in peptide methionine sulfoxide reductase in Alzheimer's disease brain. J Neurochem 73:1660-1666.
104. Gaut JP, Byun J, Tran HD, Lauber WM, Carroll JA, Hotchkiss RS, Belaaouaj A, Heinecke JW. 2002a. Myeloperoxidase produces nitrating oxidants in vivo. J Clin Invest 109:1311-1319.
105. Gaut JP, Byun J, Tran HD, Heinecke JW. 2002b. Artifact-free quantification of free 3-chlorotyrosine, 3-bromotyrosine, and 3-nitrotyrosine in human plasma by electron capturenegative chemical ionisation gas chromatography mass spectrometry and liquid chromatography-electrospray ionization tandem mass spectrometry. Anal Biochem 300:252-259.
106. Georgiou G. 2002. How to flip the (redox) switch. Cell 111:607-610.
107. Ghezzi P, Bonetto V. 2003. Redox proteomics: Identification of oxidatively modified proteins. Proteomics 3:1145-1153.
108. Ghezzi P, Romines B, Fratelli M, Eberini I, Gianazza E, Casagrande S, Laragione T, Mengozzi M, Herzenberg LA, Herzenberg LA. 2002. Protein glutathionylation: Coupling and uncoupling of glutathione to protein thiol groups in lymphocytes under oxidative stress and HIV infection. Mol Immunol 38:773-780.
109. Giasson BI, Duda JE, Murray IV, Chen Q, Souza JM, Hurtig HI, Ischiropoulos H, Trojanowski JQ, Lee VM. 2000. Oxidative damage linked to neurodegeneration by selective alphasynuclein nitration in synucleinopathy lesions. Science 290:985-989.
110. Giasson BI, Ischiropoulos H, Lee VM, Trojanowski JQ. 2002. The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's diseases. Free Radic Biol Med 32:1264-1275.
111. Giustarini D, Milzani A, Colombo R, Dalle-Donne I, Rossi R. 2003a. Nitric oxide and S-nitrosothiols in human blood. Clin Chim Acta 330:85-98.
112. Giustarini D, Dalle-Donne I, Colombo R, Milzani A, Rossi R. 2003b. An improved HPLC mesurement for GSH and GSSG in human blood. Free Radic Biol Med 35:1365-1372.
113. Gladstone IM, Jr., Levine RL. 1994. Oxidation of proteins in neonatal lungs. Pediatrics 93:764-768.
114. Glomb MA, Pfahler C. 2001. Amides are novel protein modifications formed by physiological sugars. J Biol Chem 276:41638-41647.
115. Gole MD, Souza JM, Choi I, Hertkorn C, Malcolm S, Foust RF, Finkel B, Lanken PN, Ischiropoulos H. 2000. Plasma proteins modified by tyrosine nitration in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 278:L961-967.
116. Good PF, Werner P, Hsu A, Olanow CW, Perl DP. 1996. Evidence for neuronal oxidative damage in Alzheimer's disease. Am J Pathol 149:21-28.
117. Good PF, Hsu A, Werner P, Perl DP, Olanow CW. 1998. Protein nitration in Parkinson's disease. J Neuropathol Exp Neurol 57:338-342.
118. Gow AJ, Chen Q, Hess DT, Day BJ, Ischiropoulos H, Stamler JS. 2002. Basal and stimulated protein S-nitrosylation in multiple cell types and tissues. J Biol Chem 277:9637-9640.
119. Grattagliano I, Vendemiale G, Boscia F, Micelli-Ferrari T, Cardia L, Altomare E. 1998. Oxidative retinal products and ocular damages in diabetic patients. Free Radic Biol Med 25:369-372.
120. Grattagliano I, Giudetti AM, Grattagliano V, Palmieri VO, Gnoni GV, Lapadula G, Palasciano G, Vendemiale G. 2003. Structural and oxidative modifications of erythrocyte ghosts in patients with primary biliary cirrhosis: Relation with the disease stage and effect of bile acid treatment. Eur J Clin Invest 33:868-874.
121. Greenacre SA, Ischiropoulos H. 2001. Tyrosine nitration: Localisation, quantification, consequences for protein function and signal transduction. Free Radic Res 34:541-581.
122. Griffiths HR, Moller L, Bartosz G, Bast A, Bertoni-Freddari C, Collins A, Cooke M, Coolen S, Haenen G, Hoberg AM, Loft S, Lunec J, Olinski R, Parry J, Pompella A, Poulsen H, Verhagen H, Astley SB. 2002. Biomarkers. Mol Aspects Med 23:101-208.
123. Grune T, Merker K, Sandig G, Davies KJ. 2003. Selective degradation of oxidatively modified protein substrates by the proteasome. Biochem Biophys Res Commun 305:709-718.
124. Grunert T, Pock K, Buchacher A, Allmaier G. 2003. Selective solid-phase isolation of methionine-containing peptides and subsequent matrix-assisted laser desorption/ionisation mass spectrometric detection of methionine- and of methionine-sulfoxide-containing peptides. Rapid Commun MassSpectrom 17:1815-1824.
125. Guan Z, Yates NA, Bakhtiar R. 2003. Detection and characterization of methionine oxidation in peptides by collision-induced dissociation and electron capture dissociation. J Am Soc Mass Spectrom 14:605-613.
126. Gunther MR, Tschirret-Guth RA, Witkowska HE, Fann YC, Barr DP, Ortiz De Montellano PR, Mason RP. 1998. Site-specific spin trapping of tyrosine radicals in the oxidation of metmyoglobin by hydrogen peroxide. Biochem J 330:1293-1299.
127. Halliwell B, Gutteridge JMC. 1999. Free radicals in biology and medicine. New York: Oxford University Press, Inc.
128. Hanson SR, Chen AA, Smith JB, Lou MF. 1999. Thiolation of the gammaB-crystallins in intact bovine lens exposed to hydrogen peroxide. J Biol Chem 274:4735-4742.
129. Hanson SR, Hasan A, Smith DL, Smith JB. 2000. The major in vivo modifications of the human water-insoluble lens crystallins are disulfide bonds, deamidation, methionine oxidation and backbone cleavage. Exp Eye Res 71:195-207.
130. Hara I, Ueno T, Ozaki Si, Itoh S, Lee K, Ueyama N, Watanabe Y. 2001. Oxidative modification of tryptophan 43 in the heme vicinity of the F43W/H64L myoglobin mutant. J Biol Chem 276:36067-36070.
131. Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler H. 2003. Role of oxidative stress in atherosclerosis. Am J Cardiol 91:7A-11A.
132. Hazen SL, Heinecke JW. 1997. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J Clin Invest 99:2075-2081.
133. Heinecke JW. 1999a. Mechanisms of oxidative damage by myeloperoxidase in atherosclerosis and other inflammatory disorders. J Lab Clin Med 133:321-325.
134. Heinecke JW. 1999b. Mass spectrometric quantification of amino acid oxidation products in proteins: Insights into pathways that promote LDL oxidation in the human artery wall. FASEB J 13:1113-1120.
135. Heinecke JW, Hsu FF, Crowley JR, Hazen SL, Leeuwenburgh C, Mueller DM, Rasmussen JE, Turk J. 1999c. Detecting oxidative modification of biomolecules with isotope dilution mass spectrometry: Sensitive and quantitative assays for oxidized amino acids in proteins and tissues. Methods Enzymol 300:124-144.
136. Henderson JP, Byun J, Williams MV, McCormick ML, Parks WC, Ridnour LA, Heinecke JW. 2001. Bromination of deoxycytidine by eosinophil peroxidase: A mechanism for mutagenesis by oxidative damage of nucleotide precursors. Proc Natl Acad Sci USA 98:1631-1636.
137. Hensley K, Hall N, Subramaniam R, Cole P, Harris M, Aksenov M, Aksenova M, Gabbita SP, Wu JF, Carney JM, Lovell M, Markesbery WR, Butterfield DA. 1995. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J Neurochem 165:2146-2156.
138. Hensley K, Maidt ML, Yu Z, Sang H, Markesbery WR, Floyd RA. 1998. Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. J Neurosci 18:8126-8132.
139. Hensley K, Robinson KA, Gabbita SP, Salsman S, Floyd RA. 2000. Reactive oxygen species, cell signaling, and cell injury. Free Radic Biol Med 28:1456-1462.
140. Herce-Pagliai C, Kotecha S, Shuker DE. 1998. Analytical methods for 3-nitrotyrosine as a marker of exposure to reactive nitrogen species: A review. Nitric Oxide 2:324-336.
141. Hetz C, Maundrell K, Soto C. 2003. Is loss of function of the prion protein the cause of prion disorders? Trends Mol Med 9:237-243.
142. Hilliquin P, Borderie D, Hernvann A, Menkes CJ, Ekindjian OG. 1997. Nitric oxide as S-nitrosoproteins in rheumatoid arthritis. Arthritis Rheum 40:1512-1517.
143. Himmelfarb J, McMonagle E, McMenamin E. 2000. Plasma protein thiol oxidation and carbonyl formation in chronic renal failure. Kidney Int 58:2571-2578.
144. Himmelfarb J, McMonagle E. 2001. Albumin is the major plasma protein target of oxidant stress in uremia. Kidney Int 60:358-363.
145. Himmelfarb J, McMenamin ME, Loseto G, Heinecke JW. 2001. Myeloperoxidase-catalyzed 3-chlorotyrosine formation in dialysis patients. Free Radic Biol Med 31:1163-1169.
146. Hirsch J, Elssner A, Mazur G, Maier KL, Bittmann I, Behr J, Schwaiblmair M, Reichenspurner H, Furst H, Briegel J, Vogelmeier C. 1999. Bronchiolitis obliterans syndrome after (heart-)lung transplantation. Impaired antiprotease defense and increased oxidant activity. Am J Respir Crit Care Med 160:1640-1646.
147. Hodges GR, Ingold KU. 1999. Cage escape of geminate radical pairs can produce peroxynitrate from peroxynitrite under a wide variety of experimental conditions. J Am Chem Soc 121:10695-10701.
148. Hoeldtke RD, Bryner KD, McNeill DR, Hobbs GR, Riggs JE, Warehime SS, Christie I, Ganser G, Van Dyke K. 2002. Nitrosative stress, uric acid, and peripheral nerve function in early type 1 diabetes. Diabetes 51:2817-2825.
149. Hogg N. 2002. The biochemistry and physiology of S-nitrosothiols. Annu Rev Pharmacol Toxicol 42:585-600.
150. Hollemeyer K, Heinzle E, Tholey A. 2002. Identification of oxidized methionine residues in peptides containing two methionine residues by derivatization and matrix-assisted laser desorption/ionization mass spectrometry. Proteomics 2:1524-1531.
151. Holloway JW, Jongepier H, Begh̀ B, Koppelman GH, Holgate ST, Postma DS. 2003. The genetics of asthma. In: Chung F, Fabbri LM, editors. Asthma. Sheffield, UK: ERS Journals Ltd. pp 26-56.
152. Horiguchi T, Uryu K, Giasson BI, Ischiropoulos H, LightFoot R, Bellmann C, Richter-Landsberg C, Lee VM-Y, Trojanowski JQ. 2003. Nitration of tau protein is linked to neurodegeneration in tauopathies. Am J Pathol 163:1021-1031.
153. Huang KC, Yang CC, Lee KT, Chien CT. 2003. Reduced hemodialysis-induced oxidative stress in end-stage renal disease patients by electrolyzed reduced water. Kidney Int 64:704-714.
154. Hunter GC, Henderson AM, Westerband A, Kobayashi H, Suzuki F, Yan ZQ, Sirsjo A, Putnam CW, Hansson GK. 1999. The contribution of inducible nitric oxide and cytomegalovirus to the stability of complex carotid plague. J Vasc Surg 30:36-49.
155. Ichinose M, Sugiura H, Yamagata S, Koarai A, Shirato K. 2000. Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways. Am J Respir Crit Care Med 162:701-706.
156. Inder T, Mocatta T, Darlow B, Spencer C, Volpe JJ, Winterbourn CC. 2002. Elevated free radical products in the cerebrospinal fluid of VLB W infants with cerebral white matter injury. Pediatr Res 52:213-218.
157. Jaffrey SR, Erdjument-Bromage H, Ferris CD, Tempst P, Snyder SH. 2001. Protein S-nitrosylation: A physiological signal for neuronal nitric oxide. Nat Cell Biol 3:193-197.
158. Kamisaki Y, Wada K, Bian K, Balabanli B, Davis K, Martin E, Behbod F, Lee YC, Murad F. 1998. An activity in rat tissues that modifies
159. Kaneko K, Nakamura A, Yoshida K, Kametani F, Higuchi K, Ikeda S-I. 2002. Glial fibrillary acidic protein is greatly modified by oxidative stress in aceruloplasminemia brain. Free Radic Res 36:303-306.
160. Kelly FJ, Mudway I, Blomberg A, Frew A, Sandstrom T. 1999. Altered lung antioxidant status in patients with mild asthma. Lancet 354:482-483.
161. Keshavarzian A, Banan A, Farhadi A, Komanduri S, Mutlu E, Zhang Y, Fields JZ. 2003. Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease. Gut 52:720-728.
162. Khan J, Brennand DM, Bradley N, Gao B, Bruckdorfer R, Jacobs M, Brennan DM. 1998. 3-Nitrotyrosine in the proteins of human plasma determined by an ELISA method. Biochem J 330:795-801.
163. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, Barnes PJ. 1994. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 343:133-135.
164. Kinscherf R, Deigner HP, Usinger C, Pill J, Wagner M, Kamencic H, Hou D, Schen M, Schmiedt W, Schrader M, Kovacs G, Kalo K, Metz J. 1997. Induction of mitochondrial manganese Superoxide dismutase in macrophages by oxidized LDL: Its relevance in atherosclerosis of humans and heritable hyperlipidemic rabbits. FASEB J 11:1317-1328.
165. Kinscherf R, Claus R, Wagner M, Gehrke C, Kamencic H, Hou D, Nauen O, Schmiedt W, Kovacs G, Pill J, Metz J, Deigner HP. 1998. Apoptosis caused by oxidized LDL is manganese Superoxide dismutase and p53 dependent. FASEB J 12:461-467.
166. Kinscherf R, Wagner M, Kamencic H, Bonaterra GA, Hou D, Schiele RA, Deigner HP, Metz J. 1999. Characterization of apoptotic macrophages in atheromatous tissue of humans and heritable hyperlipidemic rabbits. Atherosclerosis 144:33-39.
167. Klatt P, Lamas S. 2000. Regulation of protein function by Sglutathiolation in response to oxidative and nitrosative stress. Eur J Biochem 267:4928-4944.
168. Klatt P, Molina ES, Lacoba MC, Padilla CA, Martinez-Glaisteo E, Barcena JA, Lamas S. 1999. Redox regulation of c-Jun DNA binding by reversible S-glutathiolation. FASEB J 13:1481-1490.
169. Kooy NW, Lewis SJ, Royall JA, Ye YZ, Kelly DR, Beckman JS. 1997. Extensive tyrosine nitration in human myocardial inflammation: Evidence for the presence of peroxynitrite. Crit Care Med 25:812-819.
170. Korolainen MA, Goldsteins G, Alafuzoff I, Koistinaho J, Pirttila T. 2002. Proteomic analysis of protein oxidation in Alzheimer's disease brain. Electrophoresis 23:3428-3433.
171. Kunsch C, Medford RM. 1999. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res 85:753-766.
172. 2-treated Cu,Zn-SOD protein with LC-ESI-Q-TOFMS, MS/MS for the determination of the copper-binding site. J Am Chem Soc 123:9268-9278.
173. Lagerwerf FM, van de Weert M, Heerma W, Haverkamp J. 1996. Identification of oxidized methionine in peptides. Rapid Commun Mass Spectrom 10:1905-1910.
174. Lamb NJ, Gutteridge JM, Baker C, Evans TW, Quinlan GJ. 1999. Oxidative damage to proteins of bronchoalveolar lavage fluid in patients with acute respiratory distress syndrome: Evidence for neutrophil-mediated hydroxylation, nitration, and chlorination. Crit Care Med 27:1738-1744.
175. Lang JD, McArdle PJ, O'Reilly PJ, Matalon S. 2002. Oxidant-antioxidant balance in acute lung injury. Chest 122:314S-320S.
176. Langen RC, Korn SH, Wouters EF. 2003. ROS in the local and systemic pathogenesis of COPD. Free Radic Biol Med 35:226-235.
177. Lapolla A, Fedele D, Traldi P. 2000. The role of mass spectrometry in the study of non-enzymatic protein glycation in diabetes. Mass Spectrom Rev 19:279-304.
178. Lardinois OM, Medzihradszky KF, Ortiz de Montellano PR. 1999. Spin trapping and protein cross-linking of the lactoperoxidase protein radical. J Biol Chem 274:35441-35448.
179. Leeuwenburgh C, Hardy MM, Hazen SL, Wagner P, Ohishi S, Steinbrecher UP, Heinecke JW. 1997a. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerosis. J Biol Chem 272:1433-1436.
180. Leeuwenburgh C, Rasmussen JE, Hsu FF, Mueller DM, Pennathur S, Heinecke JW. 1997b. Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques. J Biol Chem 272:3520-3526.
181. Levine RL, Moskovitz J, Stadtman ER. 2000a. Oxidation of methionine in proteins: Roles in antioxidant defense and cellular regulation. IUBMB Life 50:301-307.
182. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz A, Ahn B, Shaltiel S, Stadtman ER. 1990. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186:464-478.
183. Levine RL, Mosoni L, Berlett BS, Stadtman ER. 1996. Methionine residues as endogenous antioxidants in proteins. Proc Natl Acad Sci USA 93:15036-15040.
184. Levine RL, Wehr N, Williams JA, Stadtman ER, Shacter E. 2000b. Determination of carbonyl groups in oxidized proteins. Methods Mol Biol 99:15-24.
185. Lim PS, Cheng YM, Wei YH. 2002. Increase in oxidative damage to lipids and proteins in skeletal muscle of uremie patients. Free Radic Res 36:295-301.
186. Lim A, Prokaeva T, McComb ME, Connors LH, Skinner M, Costello CE. 2003. Identification of S-sulfonation and S-thiolation of a novel transthyretin Phe33Cys variant from a patient diagnosed with familial transthyretin amyloidosis. Protein Sci 12:1775-1785.
187. Lind C, Gerdes R, Hamnell Y, Schuppe-Koistinen I, von Lowenhielm HB, Holmgren A, Cotgreave IA. 2002. Identification of S-glutathionylated cellular proteins during oxidative stress and constitutive metabolism by affinity purification and proteomic analysis. Arch Biochem Biophys 406:229-240.
188. Lungarella G, Cavarra E, Martorana PA. 1999. Models of genetic emphysema: The C57 B1/6J mice and their mutants: Tight-skin, pallid and beige. In: Stockley RA, editor. Molecular biology of the lung. Vol. I: Emphysema and infection. Basel: Birkhauser Verlag, pp 19-36.
189. Lusini L, Tripodi SA, Rossi R, Giannerini F, Giustarini D, del Vecchio MT, Barbanti G, Cintorino M, Tosi P, Di Simplicio P. 2001. Altered glutathione anti-oxidant metabolism during tumor progression in human renal-cell carcinoma. Int J Cancer 91:55-59.
190. Lyras L, Cairns NJ, Jenner A, Jenner P, Halliwell B. 1997. An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease. J Neurochem 68:2061-2069.
191. MacCoss MJ, McDonald WH, Saraf A, Sadygov R, Clark JM, Tasto JJ, Gould KL, Wolters D, Washburn M, Weiss A, Clark JI, Yates JR III. 2002. Shotgun identification of protein modifications from protein complexes and lens tissue. Proc Natl Acad Sci USA 99:7900-7905.
192. MacMillan-Crow LA, Crow JP, Thompson JA. 1998. Peroxynitrite-mediated inactivation of manganese Superoxide dismutase involves nitration and oxidation of critical tyrosine residues. Biochemistry 37:1613-1622.
193. MacMillan-Crow LA, Crow JP, Kerby JD, Beckman JS, Thompson JA. 1996. Nitration and inactivation of manganese Superoxide dismutase in chronic rejection of human renal allografts. Proc Natl Acad Sci USA 93:11853-11858.
194. MacPherson H, Ralston S. 2000. Nitric oxide and bone destruction. In: Winyard P, Blake D, Evans C, editors. Free radicals and inflammation. Basel: Birkhauser.
195. MacPherson JC, Comhair SA, Erzurum SC, Klein DF, Lipscomb MF, Kavuru MS, Samoszuk MK, Hazen, SL. 2001. Eosinophils are a major source of nitric oxide-derived oxidants in severe asthma: Characterization of pathways available to eosinophils for generating reactive nitrogen species. J Immunol 166:5763-5772.
196. Maier KL, Leuschel L, Costabel U. 1992. Increased oxidized methionine residues in BAL fluid proteins in acute or chronic bronchitis. Eur Respir J 5:651-658.
197. Mallozzi C, Di Stasi MA, Minetti M. 2001. Peroxynitrite-dependent activation of src tyrosine kinases lyn and hck in erythrocytes is under mechanistically different pathways of redox control. Free Radic Biol Med 30:1108-1117.
198. Mannick JB, Hausladen A, Liu L, Hess DT, Zeng M, Miao QX, Kane LS, Gow AJ, Stamler JS. 1999. Fas-induced caspase denitrosylation. Science 284:651-654.
199. Mantle D, Falkous G, Walker D. 1999. Quantification of protease activities in synovial fluid from rheumatoid and osteoar-thritis cases: Comparison with antioxidant and free radical damage markers. Clin Chim Acta 284:45-58.
200. Mapp PI, Klocke R, Walsh DA, Ghana JK, Stevens CR, Gallagher PJ, Blake DR. 2001. Localization of 3-nitrotyrosine to rheumatoid and normal synovium. Arthritis Rheum 44:1534-1539.
201. Markesbery WR. 1997. Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 23:134-147.
202. Marotta E, Lapolla A, Fedele D, Senesi A, Reitano R, Witt M, Seraglia R, Traldi P. 2003. Accurate mass measurements by Fourier transform mass spectrometry in the study of advanced glycation end products/peptides. J Mass Spectrom 38:196-205.
203. Marvin LF, Delatour T, Tavazzi I, Fay LB, Cupp C, Guy PA. 2003. Quantification of o,o′-dityrosine, o-nitrotyrosine, and o-tyrosine in cat urine samples by LC/ electrospray ionization-MS/MS using isotope dilution. Anal J Chem 75:261-267.
204. Massy ZA, Borderie D, Nguyen-Khoa T, Drueke TB, Ekindjian OG, Lacour B. 2003. Increased plasma S-nitrosothiol levels in chronic haemodialysis patients. Nephrol Dial Transplant 18:153-157.
205. Matsumoto A, Comatas KE, Liu L, Stamler JS. 2003. Screening for nitric oxide-dependent protein-protein interactions. Science 301:657-661.
206. Maurice MM, Nakamura H, Gringhuis S, Okamoto T, Yoshida S, Kullmann F, Lechner S, van-der-Voort EA, Leow A, Versendaal J, Muller-Ladner U, Yodoi J, Tak PP, Breedveld FC, Verweij CL. 1999. Expression of the thioredoxin-thioredoxin-reductase system in inflamed joints of patients with rheumatoid arthritis. Arthritis Rheum 42:2430-2439.
207. Maziak W, Loukides S, Culpitt S, Sullivan P, Kharitonov SA, Barnes PJ. 1998. Exhaled nitric oxide in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157:998-1002.
208. McKillop AM, Meade A, Flatt PR, O'Harte FP. 2003. Evaluation of the site(s) of glycation in human proinsulin by ion-trap LCQ electrospray ionization mass spectrometry. Regul Pept 113:1-8.
209. Metz TO, Alderson NL, Thorpe SR, Baynes JW. 2003. Pyridoxamine, an inhibitor of advanced glycation and lipoxidation reactions: A novel therapy for treatment of diabetic complications. Arch Biochem Biophys 419:41-49.
210. Mikkelsen RB, Wardman P. 2003. Biological chemistry of reactive oxygen and nitrogen and radiation-induced signal transduction mechanisms. Oncogene 22:5734-5754.
211. Milhavet O, Lehmann S. 2002. Oxidative stress and the prion protein in transmissible spongiform encephalopathies. Brain Res Rev 38:328-339.
212. Milhavet O, McMahon HE, Rachidi W, Nishida N, Katamine S, Mange A, Arlotto M, Casanova D, Riondel J, Favier A, Lehmann S. 2000. Prion infection impairs the cellular response to oxidative stress. Proc Natl Acad Sci USA 97:13937-13942.
213. Milzani A, Rossi R, Di Simplicio P, Giustarini D, Colombo R, Dalle-Donne I. 2000. The oxidation produced by hydrogen peroxide on Ca-ATP-G-actin. Protein Sci 9:1774-1782.
214. Minetti M, Mallozzi C, Di Stasi AM. 2002. Peroxynitrite activates kinases of the src family and upregulates tyrosine phosphorylation signaling. Free Radic Biol Med 33:744-754.
215. Minetti M, Pietraforte D, Carbone V, Salzano AM, Scorza G, Marino G. 2000. Scavenging of peroxynitrite by oxyhemo-globin and identification of modified globin residues. Biochemistry 39:6689-6697.
216. Miyata T, Inagi R, Wada Y, Ueda Y, Iida Y, Takahashi M, Taniguchi N, Maeda K. 1994. Glycation of human beta 2-microglobulin in patients with hemodialysis-associated amyloidosis: Identification of the glycated sites. Biochemistry 33:12215-12221.
217. Miyata T, Inagi R, Asahi K, Yamada Y, Horte K, Sakai H, Uchida K, Kurokawa K. 1998. Generation of protein carbonyls by glycoxidation and lipoxidation reactions with autoxidation products of ascorbic acid and polyunsaturated fatty acids. FEES Lett 437:24-28.
218. Mollace V, Nottet HSLM, Clayette P, Turco MC, Muscoli C, Salvemini D, Perno CF. 2001. Oxidative stress and neuroAIDS: Triggers, modulators and novel antioxidants. Trends Neurosci 24:411-416.
219. Moriel P, Pereira IR, Bertolami MC, Abdalla DS. 2001. Is ceruloplasmin an important catalyst for S-nitrosothiol generation in hypercholesterolemia? Free Radic Biol Med 30:318-326.
220. Morrison D, Rahman I, Lannan S, MacNee W. 1999. Epithelial permeability, inflammation, and oxidant stress in the air spaces of smokers. Am J Respir Crit Care Med 159:473-479.
221. Moskovitz J, Flescher E, Berlett BS, Azare J, Poston JM, StadtmanER. 1998. Overexpression of peptide-methionine sulfoxide reductase in Saccharomyces cerevisiae and human T cells provides them with high resistance to oxidative stress. Proc Natl Acad Sci USA 95:14071-14075.
222. Moskovitz J, Bar-Noy S, Williams WM, Requena J, Berlett BS, Stadtman ER. 2001. Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals. Proc Natl Acad Sci USA 98:12920-12925.
223. Moskovitz J, Singh VK, Requena J, Wilkinson BJ, Jayaswal RK, Stadtman ER. 2002. Purification and characterization of methionine sulfoxide reductases from mouse and Staphylo-coccus aureus and their substrate stereospecificity. Biochem Biophys Res Commun 290:62-65.
224. Murray J, Taylor SW, Zhang B, Ghosh SS, Capaldi RA. 2003. Oxidative damage to mitochondrial complex I due to peroxynitrite: Identification of reactive tyrosines by mass spectrometry. J Biol Chem 278:37223-37230.
225. Myatt L, Rosenfield RB, Eis AL, Brockman DE, Greer I, Lyall F. 1996. Nitrotyrosine residues in placenta. Evidence of peroxynitrite formation and action. Hypertension 28:488-493.
226. Nadeem A, Chhabra SK, Masood A, Raj HG. 2003. Increased oxidative stress and altered levels of antioxidants in asthma. J Allergy Clin Immunol 111:72-78.
227. Naito C, Niwa T. 2000. Analysis of glutathionyl hemoglobin levels in diabetic patients by electrospray ionization liquid chromatography-mass spectrometry: Effect of vitamin E administration. J Chromatogr B Biomed Sci Appl 746:91-94.
228. Nakamura H, Masutani H, Yodoi J. 2002. Redox imbalance and its control in HIV infection. Antiox Redox Signaling 4:455-464.
229. Naslund J, Schierhorn A, Hellman U, Lannfelt L, Roses AD, Tjernberg LO, Silberring J, Gandy SE, Winblad B, Green-gard P, Nordstedt C, Terenius L. 1994. Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging. Proc Natl Acad Sci USA 91:8378-8382.
230. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Gates PJ, Hammes HP, Giardino I, Brownlee M. 2000. Normalizing mitochondria1 superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787-790.
231. Niwa T, Naito C, Mawjood AHM, Imai K. 2000. Increased glutathionyl hemoglobin in diabetes mellitus and hyperlipidemia demonstrated by liquid chromatography/electrospray ionization-mass spectrometry. Clin Chem 46:82-88.
232. Okamoto T, Akaike T, Sawa T, Miyamoto Y, van der Vliet A, Maeda H. 2001. Activation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation. J Biol Chem 276:29596-29602.
233. Page NM, Woods RJ, Gardiner SM, Lomthaisong K, Gladwell RT, Butlin DJ, Manyonda IT, Lowry PJ. 2000. Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia. Nature 405:797-800.
234. Pandey A, Mann M. 2000. Proteomics to study genes and genomes. Nature 405:837-846.
235. Panek J, Vohradsky J. 1999. Point pattern matching in the analysis of twodimensional gel electropherograms. Electrophoresis 20:3483-3491.
236. Paron I, D'Elia A, D'Ambrosio C, Scaloni A, D'Aurizio F, Prescott A, Damante G, Tell G. 2003. A proteomic approach to identify early molecular targets of oxidative stress in human epithelial lens cells. Biochem J 2003 Dec 16 [Epub ahead of print; DOI 10.1042/BJ2003/190].
237. Pasinelli P, Houseweart MK, Brown RH, Jr., Cleveland DW. 2000. Caspase-1 and -3 are sequentially activated in motor neuron death in Cu,Zn Superoxide dismutase-mediated familial amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 97:13901-13906.
238. Pastore A, Tozzi G, Gaeta LM, Giannotti A, Bertini E, Federici G, Digilio MC, Piemonte F. 2003a. Glutathione metabolism and antioxidant enzymes in children with Down's syndrome. J Pediatr 142:583-585.
239. Pastore A, Tozzi G, Gaeta LM, Bertini E, Serafini V, Di Cesare S, Bonetto V, Casoni F, Carrozzo R, Federici G, Piemonte F. 2003b. Actin glutathionylation increases in fibroblasts of patients with Friedreich's ataxia: A potential role in the pathogenesis of the disease. J Biol Chem 43:42588-42595.
240. Pennathur S, Jackson-Lewis V, Przedborski S, Heinecke JW. 1999. Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and o,o′-dityrosine in brain tissue of 1-methyl-4-phenyl-l,2,3,6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson's disease. J Biol Chem 274:34621-34628.
241. Peterson KP, Pavlovich JG, Goldstein D, Little R, England J, Peterson CM. 1998. What is hemoglobin A1c? An analysis of glycated hemoglobins by electrospray ionization mass spectrometry. Clin Chem 44:1951-1958.
242. Petersson AS, Steen H, Kalume DE, Caidahl K, Roepstorff P. 2001. Investigation of tyrosine nitration in proteins by mass spectrometry. J Mass Spectrom 36:616-625.
243. Piemonte F, Pasture A, Tozzi G, Tagliacozzi D, Santarelli FM, Carrozzo R, Casali C, Damiano M, Federici G, Bestini E. 2001. Glutathione in blood of patients with Friedreich's ataxia. Eur J Clin Invest 31:1007-1011.
244. Pietraforte D, Salzano AM, Scorza G, Marino G, Minetti M. 2002. Mechanism of peroxynitrite interaction with ferric hemoglobin and identification of nitrated tyrosine residues. CO(2) inhibits heme-catalyzed scavenging and isomerization. Biochemistry 40:15300-15309.
245. Pignatelli B, Li CQ, Boffetta P, Chen Q, Ahrens W, Nyberg F, Mukeria A, Bruske-Hohlfeld I, Fortes C, Constantinescu V, Ischiropoulos H, Ohshima H. 2001. Nitrated and oxidized plasma proteins in smokers and lung cancer patients. Cancer Res 61:778-784.
246. Pinamonti S, Muzzoli M, Chicca MC, Papi A, Ravenna F, Fabbri LM, Ciaccia A. 1996. Xanthine oxidase activity in bronchoalveolar lavage fluid from patients with chronic obstructive pulmonary disease. Free Radic Biol Med 21:147-155.
247. Podrez EA, Abu-Soud HM, Hazen SL. 2000. Myeloperoxidase-generated oxidants and atherosclerosis. Free Radic Biol Med 28:1717-1725.
248. Poggioli S, Bakala H, Friguet B. 2002. Age-related increase of protein glycation in peripheral blood lymphocytes is restricted to preferential target proteins. Exp Gerontol 37:1207-1215.
249. Powell SA, Gurzenda EM, Wahezi SE. 2001. Actin is oxidized during myocardial ischemia. Free Radic Biol Med 30:1171-1176.
250. Praticò D, Basili S, Vieri M, Cordova C, Violi F, Fitzgerald GA. 1998a. Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress. Am J Respir Crit Care Med 158:1709-1714.
251. Praticò D, Lee VM-Y, Trojanowski JQ, Rokach J, Fitzgerald GA. 1998b. Increased F2-isoprostanes in Alzheimer's disease: Evidence for enhanced lipid peroxidation in vivo. FASEB J 12:1777-1783.
252. Previero A, Coletti-Previero MA, Jolies P. 1967. Localization of non-essential tryptophan residues for the biological activity of lysozyme. J Mol Biol 24:261-268.
253. Prusiner SB, Scott MR, Dearmond SJ, Cohen FE. 1998. Prion protein biology. Cell 93:337-348.
254. Pryor WA. 2001. Bio-assays for oxidative stress status (BOSS). Amsterdam: Elsevier Science B.V, 286 p.
255. Rabek JP, Boylston WH III, Papaconstantinou J. 2003. Carbonylation of ER chaperone proteins in aged mouse liver. Biochem Biophys Res Commun 305:566-572.
256. Rabilloud T, Heller M, Gasnier F, Luche S, Rey C, Aebersold R, Benahmed M, Louisot P, Lunardi J. 2002. Proteomics analysis of cellular response to oxidative stress. Evidence for in vivo overoxidation of peroxiredoxins at their active site. J Biol Chem 277:19396-19401.
257. Rahman I, Skwarska E, MacNee W. 1997. Attenuation of oxidant/antioxidant imbalance during treatment of exacerbations of chronic obstructive pulmonary disease. Thorax 52:565-568.
258. Rahman I, MacNee W. 1996. Role of oxidants/antioxidants in smoking-induced lung diseases. Free Radic Biol Med 21:669-681.
259. Rahman I, MacNee W. 1998. Role of transcription factors in inflammatory lung diseases. Thorax 53:601-612.
260. Rahman I, Morrison D, Donaldson K, MacNee W. 1996. Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Care Med 154:1055-1060.
261. Rahman I, van Schadewijk AA, Crowther AJ, Hiemstra PS, Stolk J, MacNee W, De Boer WI. 2002. 4-Hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 166:490-495.
262. Ramsay PL, Demayo FJ, Hegemier SE, Wearden ME, Smith CV, Welty SE. 2001. Clara cell secretory protein oxidation and expression in premature infants who develop bronchopulmonary dysplasia. Am J Respir Crit Care Med 164:155-161.
263. Renke J, Popadiuk S, Korzon M, Bugajczyk B, Wozniak M. 2000. Protein carbonyl groups content as a useful clinical marker of antioxidant barrier impairment in plasma of children with juvenile chronic arthritis. Free Radic Biol Med 29:101-104.
264. Requena JR, Fu MX, Ahmed MU, Jenkins AJ, Lyons TJ, Baynes JW, Thorpe SR. 1997. Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein. Biochem J 322:317-325.
265. Requena JR, Chao CC, Levine RL, Stadtman ER. 200la. Glutamic and aminoadipic semialdehydes are the main carbonyl products of metal-catalyzed oxidation of proteins. Proc Natl Acad Sci USA 98:69-74.
266. Requena JR, Groth D, Legname G, Stadtman ER, Prusiner SB, Levine RL. 2001b. Copper-catalyzed oxidation of the recombinant SHa(29-231) prion protein. Proc Natl Acad Sci USA 98:7170-7175.
267. Rijcken B, Britton J. 1998. Epidemiology of chronic obstructive pulmonary disease. In: Postma DS, Siafakas NM, editors. Management of chronic obstructive pulmonary disease. Sheffield, UK: ERS Journals Ltd. pp 41-73.
268. Roberts JM, Cooper DW. 2001. Pathogenesis and genetics of preeclampsia. Lancet 357:53-56.
269. Roberts JM, Hubel CA. 1999. Is oxidative stress the link in the two-stage model of pre-eclampsia? Lancet 354:788-789.
270. Roberts JM, Redman CW. 1993. Pre-eclampsia: More than pregnancy-induced hypertension. Lancet 341:1447-1451.
271. Rosen P, Nawroth PP, King G, Moller W, Tritschler H-J, Packer L. 2001. The role of oxidative stress in the onset and progression of diabetes and its complications: A summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev 17:189-212.
272. Ruan H, Tang XD, Chen ML, Joiner ML, Sun G, Brot N, Weissbach H, Heinemann SH, Iverson L, Wu CF, Hoshi T, Chen ML, Joiner MA, Heinemann SH. 2002. High-quality life extension by the enzyme peptide methionine sulfoxide reductase. Proc Natl Acad Sci USA 99:2748-2753.
273. Saetta M, Turato G, Maestrelli P, Mapp CE, Fabbri LM. 2001. Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163:1304-1309.
274. Sandhu JK, Robertson S, Birnboim HC, Goldstein R. 2003. Distribution of protein nitrotyrosine in synovial tissues of patients with rheumatoid arthritis and osteoarthritis. J Rheumatol 30:1173-1181.
275. Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman CW, Pfeiffer E, Schneider LS, Thal LJ. 1997. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's disease cooperative study. N Engl J Med 336:1216-1222.
276. Sanz-Cameno P, Medina J, Garcia-Buey L, Garcia-Sanchez A, Borque MJ, Martin-Vilchez S, Gamallo C, Jones EA, Moreno-Otero R. 2002. Enhanced intrahepatic inducible nitric oxide synthase expression and nitrotyrosine accumulation in primary biliary cirrhosis and autoimmune hepatitis. J Hepatol 37:723-729.
277. Saraswathi M, Nakanishi T, Shimizu A. 1999. Relative quantification of glycated Cu-Zn Superoxide dismutase in erythrocytes by electrospray ionization mass spectrometry. Biochim Biophys Acta 1426:483-490.
278. Sarver A, Scheffler NK, Shetlar MD, Gibson BW. 2001. Analysis of peptides and proteins containing nitrotyrosine by matrix-assisted laser desorption/ionization mass spectrometry. J Am Soc Mass Spectrom 12:439-448.
279. Scaloni A, Perillo V, Franco P, Fedele E, Froio R, Ferrara L, Bergamo P. 2002. Characterization of heat-induced lactosylation products in caseins by immunoenzymatic and mass spectrometric methodologies. Biochim Biophys Acta 1598:30-39.
280. Schafer FQ, Buettner GR. 2001. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/ glutathione couple. Free Radic Biol Med 30:1191-1212.
281. Schett G, Tohidast-Akrad M, Steiner G, Smolen J. 2001. The stressed synovium. Arthritis Res 3:80-86.
282. Schey KL, Finley EL. 2000. Identification of peptide oxidation by tandem mass spectrometry. Ace Chem Res 33:299-306.
283. Schock BC, Sweet DG, Halliday HL, Young IS, Ennis M. 2001. Oxidative stress in lavage fluid of preterm infants at risk of chronic lung disease. Am J Physiol Lung Cell Mol Physiol 281:L1386-L1391.
284. Schoneich C, Williams TD. 2002. Cu(II)-catalyzed oxidation of beta-amyloid peptide targets His 13 and His14 over His6: Detection of 2-oxo-histidine by HPLC-MS/MS. Chem Res Toxicol 15:717-722.
285. Schwaller M, Wilkinson B, Gilbert HF. 2003. Reduction-reoxidation cycles contribute to catalysis of disulfide isomerization by protein-disulfide isomerase. J Biol Chem 278:7154-7159.
286. Shacter E, Williams JA, Lim M, Levine RL. 1994. Differential susceptibility of plasma proteins to oxidative modification. Examination by Western blot immunoassay. Free Radic Biol Med 17:429-437.
287. Shigenaga MK, Lee HH, Blount BC, Christen S, Shigeno ET, Yip H, Ames BN. 1997. Inflammation and NO(X)-induced nitration: Assay for 3-nitrotyrosine by HPLC with electro-chemical detection. Proc Natl Acad Sci USA 94:3211-3216.
288. Shishehbor MH, Aviles RJ, Brennan ML, Fu X, Goormastic M, Pearce GL, Gokce N, Keaney JF, Penn MS, Sprecher DL, Vita JA, Hazen SL. 2003. Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy. JAMA 289:1675-1680.
289. Singer II, Kawka DW, Scott S, Weidner JR, Mumford RA, Riehl TE, Stenson WF. 1996. Expression of inducible nitric oxide synthase and nitrotyrosine in colonie epithelium in inflammatory bowel disease. Gastroenterology 111:871-885.
290. Sittipunt C, Steinberg KP, Ruzinski JT, Myles C, Zhu S, Goodman RB, Hudson LD, Matalon S, Martin TR. 2001. Nitric oxide and nitrotyrosine in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 163:503-510.
291. Smith MA, Perry G, Richey PL, Sayre LM, Anderson UE, Beal MF, Kowall N. 1996. Oxidative damage in Alzheimer's. Nature 382:120-121.
292. Smith MA, Richey Harris PL, Sayre LM, Beckman G, Perry GJ. 1997. Widespread peroxynitrite-mediated damage in Alzheimer's disease. Neuroscience 17:2653-2657.
293. Smith MA, Rottkamp CA, Nunomura A, Raina AK, Perry G. 2000. Oxidative stress in Alzheimer's disease. Biochim Biophys Acta 1502:139-144.
294. Smith MA, Casadesus G, Joseph JA, Perry G. 2002. Amyloid-ß and τ serve antioxidant functions in the aging and Alzheimer brain. Free Radic Biol Med 33:1194-1199.
295. Sochaski MA, Jenkins AJ, Lyons TJ, Thorpe SR, Baynes JW. 2001. Isotope dilution gas chromatography/mass spectrometry method for the determination of methionine sulfoxide in protein. Anal Chem 73:4662-4667.
296. Song EJ, Kim YS, Chung JY, Kim E, Chae SK, Lee KJ. 2000. Oxidative modification of nucleoside diphosphate kinase and its identification by matrix-assisted laser desorption/ ionization time-of-flight mass spectrometry. Biochemistry 39:10090-10097.
297. Stadtman ER, Berlett BS. 1998. Reactive oxygen-mediated protein oxidation in aging and disease. Drug Metab Rev 30:225-243.
298. Stadtman ER, Moskovitz J, Berlett BS, Levine RL. 2002. Cyclic oxidation and reduction of protein methionine residues is an important antioxidant mechanism. Mol Cell Biochem 234-235:3-9.
299. Stamler JS, Lamas S, Fang FC. 2001. Nitrosylation. The prototypic redox-based signaling mechanism. Cell 106:675-683.
300. Su JH, Deng GM, Cotman CW. 1997. Neuronal DNA damage precedes tangle formation and is associated with upregulation of nitrotyrosine in Alzheimer's brain. Brain Res 774:193-199.
301. Sullivan DM, Wehr NB, Fergusson MM, Levine RL, Finkel T. 2000. Identification of oxidant-sensitive proteins: TNF-α induces protein glutathiolation. Biochemistry 39:11121-11128.
302. Suzuki D, Miyata T, Saotome N, Horie K, Inagi R, Yasuda Y, Uchida K, Izuhara Y, Yagame M, Sakai H, Kurokawa K. 1999. Immunohistochemical evidence for an increased Oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions. J Am Soc Nephrol 10:822-832.
303. Synek M, Beasley R, Frew AJ, Goulding D, Holloway L, Lampe FC, Roche WR, Holgate ST. 1996. Cellular infiltration of the airways in asthma of varying severity. Am J Respir Crit Care Med 154:224-230.
304. Taggart C, Cervantes-Laurean D, Kim G, McElvaney NG, Wehr N, Moss J, Levine RL. 2000. Oxidation of either methionine 351 or methionine 358 in alpha 1-antitrypsin causes loss of anti-neutrophil elastase activity. J Biol Chem 275:27258-27265.
305. Takahashi M, Lu YB, Myint T, Fujii J, Wada Y, Taniguchi N. 1995. In vivo glycation of aldehyde reductase, a major 3-deoxyglucosone reducing enzyme: Identification of glycation sites. Biochemistry 34:1433-1438.
306. Takayama F, Tsutsui S, Horie M, Shimokata K, Niwa T. 2001. Glutathionyl hemoglobin in uremie patients undergoing hemodialysis and continuous ambulatory peritoneal dialysis. Kidney Int Suppl 78:S155-158.
307. Tarpey M, Fridovich I. 2001. Methods of detection of vascular reactive species. Nitric oxide, Superoxide, hydrogen peroxide, and peroxynitrite. Circ Res 89:224-236.
308. Taylor SW, Fahy E, Murray J, Capaldi RA, Ghosh SS. 2003. Oxidative post-translational modification of tryptophan residues in cardiac mitochondrial proteins. J Biol Chem 278:19587-19590.
309. Telci A, Cakatay U, Kayali R, Erdogan C, Orhan Y, Sivas A, Akcay T. 2000a. Oxidative protein damage in plasma of type 2 diabetic patients. Horm Metab Res 32:40-43.
310. Telci A, Cakatay U, Salman S, Satman I, Sivas A. 2000b. Oxidative protein damage in early stage Type 1 diabetic patients. Diabetes Res Clin Pract 50:213-223.
311. Tell G, Scaloni A, Pellizzari L, Formisano S, Pucillo C, Damante G. 1998. Redox potential controls the structure and DNA binding activity of the paired domain. J Biol Chem 273:25062-25072.
312. Thornalley PJ. 2002. Glycation in diabetic neuropathy: Characteristics, consequences, causes, and therapeutic options. Int Rev Neurobiol 50:37-57.
313. Tohgi H, Abe T, Yamazaki K, Murata T, Ishizaki E, Isobe C. 1999. Remarkable increase in cerebrospinal fluid 3-nitrotyrosine in patients with sporadic amyotrophic lateral sclerosis. Ann Neurol 46:129-131.
314. Torre D, Pugliese A, Speranza F. 2002. Role of nitric oxide in HIV-1 infection: Friend or foe? Lancet Infect Dis 2:273-280.
315. Tsikas D, Schwedhelm E, Stutzer FK, Gutzki FM, Rode I, Mehls C, Frolich JC. 2003. Accurate quantification of basal plasma levels of 3-nitrotyrosine and 3-nitrotyrosinoalbumin by gas chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 784:77-90.
316. Turchan J, Pocernich CB, Gairola C, Chauhan A, Schifitto G, Butterfield DA, Buch S, Narayan O, Sinai A, Geiger J, Berger JR, Elford H, Nath A. 2003. Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants. Neurology 60:307-314.
317. Tyurin VA, Liu SX, Tyurina YY, Sussman NB, Hubel CA, Roberts JM, Taylor RN, Kagan VE. 2001. Elevated levels of S-nitrosoalbumin in preeclampsia plasma. Circ Res 88:1210-1215.
318. Upston JM, Niu X, Brown AJ, Mashima R, Wang H, Senthilmohan R, Kettle AJ, Dean RT, Stocker R. 2002. Disease stage-dependent accumulation of lipid and protein oxidation products in human atherosclerosis. Am J Pathol 160:701-710.
319. Valentine JS. 2002. Do oxidatively modified proteins cause ALS? Free Radic Biol Med 33:1314-1320.
320. Van der Vliet A, Eiserich JP, Shigenaga MK, Cross CE. 1999. Reactive nitrogen species and tyrosine nitration in the respiratory tract: Epiphenomena or a pathobiologic mechanism of disease? Am J Respir Crit Care Med 160:1-9.
321. Van der Vliet A, Nguyen MN, Shigenaga MK, Eiserich JP, Marelich GP, Cross CE. 2000. Myeloperoxidase and protein oxidation in cystic fibrosis. Am J
322. van Montfort RL, Congreve M, Tisi D, Carr R, Jhoti H. 2003. Oxidation state of the active-site cysteine in protein tyrosine phosphatase IB. Nature 423:773-777.
323. Varadarajan S, Yatin SM, Aksenova M, Butterfield DA. 2000. Alzheimer's amyloid β peptide-associated free radical oxidative stress and neurotoxicity. J Struct Biol 130:184-208.
324. Varsila E, Pesonen E, Andersson S. 1995. Early protein oxidation in the neonatal lung is related to development of chronic lung disease. Acta Paediatr 84:1296-1299.
325. Veale DJ, Maple C. 1996. Cell adhesion molecules in rheumatoid arthritis. Drugs Aging 9:87-92.
326. Vilardo PG, Scaloni A, Amodeo P, Barsotti C, Cecconi I, Cappiello M, Lopez Mendez B, Rullo R, Dal Monte M, Del Corso A, Mura U. 2001. Thiol/ disulfide interconversion in bovine lens aldose reductase induced by intermediates of glutathione turnover. Biochemistry 40:11985-11994.
327. Viner RI, Williams TD, Schoneich C. 1999. Peroxynitrite modification of protein thiols: Oxidation, nitrosylation, and S-glutathiolation of functionally important cysteine residue(s) in the sarcoplasmic reticulum Ca-ATPase. Biochemistry 38:12408-12415.
328. Vogt W. 1995. Oxidation of methionyl residues in proteins: Tools, targets, and reversal. Free Radic Biol Med 18:93-106.
329. Weissbach H, Etienne F, Hoshi T, Heinemann SH, Lowther WT, Matthews B, St John G, Nathan C, Brot N. 2002. Peptide methionine sulfoxide reductase: Structure, mechanism of action, and biological function. Arch Biochem Biophys 397:172-178.
330. Wildhirt SM, Weis M, Schulze C, Conrad N, Pehlivanli S, Rieder G, Enders G, von Scheldt W, Reichart B. 2001. Expression of endomyocardial nitric oxide synthase and coronary endothelial function in human cardiac allografts. Circulation 104:1336-1343.
331. Winterbourn CC, Vissers MC, Kettle AJ. 2000a. Myeloperoxidase. Curr Opin Hematol 7:53-58.
332. Winterbourn CC, Kettle AJ. 2000. Biomarkers of myeloperox-idase-derived hypochlorous acid. Free Radic Biol Med 29:403-409.
333. Winterbourn CC, Buss IH, Chan TP, Plank LD, Clark MA, Windsor JA. 2000. Protein carbonyl measurements show evidence of early oxidative stress in critically ill patients. Crit Care Med 28:143-149.
334. Winterbourn CC, Bonham MJ, Buss H, Abu-Zidan FM, Windsor JA. 2003. Elevated protein carbonyls as plasma markers of oxidative stress in acute pancreatitis. Pancreatology 3:375-382.
335. Woo HA, Chae HZ, Hwang SC, Yang KS, Kang SW, Kim K, Rhee SG. 2003. Reversing the inactivation of peroxiredoxins caused by cysteine sulfinic acid formation. Science 300:653-656.
336. Wood ZA, Schroder E, Robin Harris J, Poole LB. 2003. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci 28:32-40.
337. Woods AA, Linton SM, Davies MJ. 2003. Detection of HOCl-mediated protein oxidation products in the extracellular matrix of human atherosclerotic plaques. Biochem J 370:729-735.
338. Wu SM, Pizzo SV. 2001. Alpha(2)-Macroglobulin from rheumatoid arthritis synovial fluid: Functional analysis defines a role for oxidation in inflammation. Arch Biochem Biophys 391:119-126.
339. Wu W, Chen BK, d'Avignon A, Hazen SL. 1999. 3-Bromotyrosine and 3,5-dibromotyrosine are major products of protein oxidation by eosinophil peroxidase: Potential markers for eosinophil-dependent tissue injury in vivo. Biochemistry 38:3538-3548.
340. Wu W, Samoszuk MK, Comhair SAA, Thomassen MJ, Farver CF, Dweik RA, Kavuru MS, Erzurum SC, Hazen SL. 2000. Eosinophils generate brominating oxidants in allergen-induced asthma. J Clin Invest 105:1455-1463.
341. Wu CT, Eiserich JP, Ansari AA, Coppel RL, Balasubramanian S, Bowlus CL, Gershwin ME, Van De Water J. 2003. Myeloperoxidase-positive inflammatory cells participate in bile duct damage in primary biliary cirrhosis through nitric oxide-mediated reactions. Hepatology 38:1018-1025.
342. Yan LJ, Sohal RS. 1998. Gel electrophoretic quantitation of protein carbonyls derivatized with tritiated sodium borohydride. Anal Biochem 265:176-182.
343. Yan SD, Schmidt AM, Anderson GM, Zhang J, Brett J, Zou YS, Pinsky D, Stern D. 1994. Enhanced cellular oxidative stress by the interaction of advanced glycation end-products with their receptors/binding protein. J Biol Chem 269:9889-9897.
344. Yang KS, Kang SW, Woo HA, Hwang SC, Chae HZ, Kim K, Rhee SG. 2002. Inactivation of human peroxiredoxin I during catalysis as the result of the oxidation of the catalytic site cysteine to cysteine-sulfinic acid. J Biol Chem 277:38029-38036.
345. Ye YZ, Strong M, Huang ZQ, Beckman JS. 1996. Antibodies that recognize nitrotyrosine. Methods Enzymol 269:201-209.
346. Yi D, Ingelse BA, Duncan MW, Smythe GA. 2000. Quantification of 3-nitrotyrosine in biological tissues and fluids: Generating valid results by eliminating artifactual formation. J Am Soc Mass Spectrom 11:578-586.
347. Yorek MA. 2003. The role of oxidative stress in diabetic vascular and neural disease. Free Radic Res 37:471-480.
348. Zech B, Wilm M, van Eldik R, Brune B. 1999. Mass spectrametric analysis of nitric oxide-modified caspase-3. J Biol Chem 274:20931-20936.
349. Zelko IN, Mariani TJ, Folz RJ. 2002. Superoxide dismutase multigene family: A comparison of the Cu,Zn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med 33:337-349.
350. Zhang H, He S, Mauk AG. 2002. Radical formation at Tyr39 and Tyr153 following reaction of yeast cytochrome c peroxidase with hydrogen peroxide. Biochemistry 41:13507-13513.
351. Zheng M, Aslund F, Storz G. 1998. Activation of the OxyR transcription factor by reversible disulfide bond formation. Science 279:1718-1721.
352. Zhou Y, Damsky CH, Fisher SJ. 1997. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this sindrome? J Clin Invest 99:2152-2164.
353. Zhu S, Basiouny KF, Crow JP, Matalon S. 2000. Carbon dioxide enhances nitration of surfactant protein A by activated alveolar macrophages. Am J Physiol 278:L1025-L1031.
354. Zhu S, Ware LB, Geiser T, Matthay MA, Matalon S. 2001. Increased levels of nitrate and surfactant protein A nitration in the pulmonary edema fluid of patients with acute lung injury. Am J Respir Crit Care Med 163:166-172.
355. Ziouzenkova O, Asatryan L, Akmal M, Tetta C, Wratten ML, Loseto-Wich G, Jurgens G, Heinecke J, Sevanian A. 1999. Oxidative cross-linking of ApoB100 and hemoglobin results in low density modification in blood. Relevance to atherogenesis caused by hemodialysis. J Biol Chem 274:18916-18924.
356. Zusterzeel PL, Mulder TP, Peters WH, Wiseman SA, Steegers EA. 2000. Plasma protein carbonyls in nonpregnant, healthy pregnant and preeclamptic women. Free Radic Res 33:471-476.
357. Zusterzeel PL, Rutten H, Roelofs HM, Peters WH, Steegers EA. 2001. Protein carbonyls in decidua and placenta of pre-eclamptic women as markers for oxidative stress. Placenta 22:213-219.